1 out of 4 CBD Products is NOT Tested

for Microbial Content, Pesticides, or Heavy Metals 

The CBD industry’s peer-reviewed watchdog Leafreport.com recently undertook an comprehensive review of 2946 products from 136 brands to verify how many were being tested by third-party facilities for purity or potency. The report also released a list of the top ten most transparent brands.

“The CBD industry is still very unregulated,” said Shafir, the head of product at Leafreport. “There have been many cases of companies selling products that contain little to no CBD–that’s why third-party testing is so critical for brands in this industry.”

Pure, Clean CBD? It’s Unlikely: Only 13% of Brands Tested Almost All of Their Products for Purity

‘Clean’, ‘safe’, ‘natural’, or ‘pure’ CBD are pivotal selling points for many CBD brands. However, these buzz words are meaningless without the evidence to support such claims.

One of the key findings of the report was that only 13% of CBD companies tested almost all of their products for detectable levels of contaminants such as heavy metals, pesticides, or microbial content. But 25% didn’t test any of their products for purity at all.

“We were stunned to find that of the big-name brands we reviewed, one in four didn’t test any of their products for the presence of contaminants,” said Shafir. “It’s particularly concerning given that hemp, from which CBD is extracted, is a phyto-remedial plant that absorbs toxins and heavy metals from the soil”.

Do Most CBD Products Deliver the Promised Potency? Don’t Bet on It–84% Don’t Measure within the Acceptable Variance

Among other key findings exposed by the report were significant discrepancies between the product’s labelled potency compared with the contents of the bottle.

The concentration of CBD stated on a product label must match the concentration measured by the testing laboratory within a 10% variance, which means that a high-quality CBD product is expected to have CBD levels that are within 90–110% of what is advertised.

84% of the 2946 products tested were found to be outside the limits of acceptable variance. Leafreport also uncovered that only 42% of brands tested all their products for potency.

“The number of brands sidestepping third-party potency testing, or testing outside the allowable variance, is a genuine source of concern,” commented Shafir.

“Testing to ensure the potency of your product is accurate is a fundamental aspect of brand integrity–especially in the case of CBD products that are frequently used as medicine. Children diagnosed with rare forms of pediatric epilepsy use CBD to help control seizures, so it’s absolutely essential that their caregivers know what’s in the bottle to get dosage right.”

Less is More: Brands with Fewer than 8 Products are More Likely to Test for Both Purity and Potency

Another telling finding revealed by the report was that brands offering 7 products or less were more likely to test most of their products for both potency and purity, as opposed to brands with over 40 products. These results suggest that third-party testing may be more manageable, and financially practicable, for brands with fewer products.

It’s Time for CBD Brands to Level Up and Become More Accountable

Overall, the findings of the report indicate that vast discrepancies and unknowns characterize what consumers believe they are purchasing–and the actual contents of the CBD product.

“The excitement generated by CBD has led to the explosion of largely unregulated industry that must become more accountable to consumers,” reflected Shafir.

Transparency report summary

 

http://d1h.7b5.myftpupload.com/industry-insights/1-out-of-4-cbd-products-is-not-tested/?fbclid=IwAR0ih9_—UVMaK3xssQ6gXX17GwuP4fDbbXSRKDVZMz0krJ7UKUkkIpUf4

 

 

Recent Articles

Even without the representation and recognition they deserve, women have always been at the center of the cannabis movement.
There are objects Americans buy because they need them, and objects Americans buy because they let them be a certain kind of person. A perfectly functional version exists, usually for a fraction of the price. But the other version comes with a name, a story, and a reason to pay extra.
Walk into any warehouse rave, desert gathering, or rooftop after-hours in 2026, and you’ll feel it: the psychedelic underground is back, louder, weirder, and far more self-aware than its ‘60s predecessor ever imagined.
In 62 BC, Julius Caesar announced his plan to divorce his second wife, Pompeia. She had been involved in an ancient Roman sex scandal, accused of flirting with another man during a women-only religious event.
ile Mike Wittenberg sat in a Dominican Republic prison, a thought occurred to him. “I could appreciate flushing the toilet,” he said. “When you’re in a third-world jail without running water 23.5 hours a day, you learn to appreciate the little things.”
When it comes to marketing, cannabis is different from every other consumer good available today. If sales start to dip in traditional retail, you can simply increase ad spending. However, with companies like Google, Meta, and even traditional broadcasters placing strict bans or severe limitations on cannabis advertising, the standard “pay-to-play” system just doesn’t work.
It feels impossible sometimes to escape the more ridiculousness aspects of pop culture—like pickleball, whatever a Labubu is, and the inevitable media frenzy surrounding Taylor Swift and Travis Kelce's upcoming wedding. Thankfully, there’s at least one trend that’s still on the rise that I can get behind, which is kratom.
When Adelia Carrillo (Fakhri) and Parisa Rad first sat down for brunch in Phoenix, AZ, with a few other women in the cannabis industry, they had no idea how that moment would change the trajectory of their lives. “The energy in that room was transformative,” Adelia says.